Vistagen Therapeutics names new CFO, shares rise
22/08/2023 15:17
** Shares of late clinical-stage biopharmaceutical co
Vistagen Therapeutics Inc VTGN.O up 2.2% at $5.46
** Co Appoints Cindy Anderson as CFO, effective Aug. 21
** Anderson will succeed Jerrold Dotson, whose retirement
was announced in July
** VTGN shares up 75.7% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors